SMS Lifesciences India Limited (SMSLIFE.BO)
INR 1431.3
(12.48%)
INR 1431.3
(12.48%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.96 Billion INR | -4.74% |
| 2022 | 2.06 Billion INR | 7.74% |
| 2021 | 1.91 Billion INR | 10.83% |
| 2020 | 1.73 Billion INR | 26.25% |
| 2019 | 1.37 Billion INR | -16.13% |
| 2018 | 1.63 Billion INR | 85.23% |
| 2017 | 882.46 Million INR | -5.52% |
| 2016 | 934 Million INR | -9.51% |
| 2015 | 1.03 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -1.93 Billion INR | -198.35% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 1.96 Billion INR | -4.74% |
| 2023 Q4 | 1.96 Billion INR | 0.0% |
| 2023 Q2 | 1.66 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 1.92 Billion INR | 0.0% |
| 2022 FY | 2.06 Billion INR | 7.74% |
| 2022 Q4 | 2.06 Billion INR | 0.0% |
| 2021 Q4 | 1.91 Billion INR | 0.0% |
| 2021 Q2 | 2 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 1.91 Billion INR | 10.83% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 1.73 Billion INR | 26.25% |
| 2020 Q4 | 1.73 Billion INR | 0.0% |
| 2020 Q2 | 1.48 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 1.41 Billion INR | 0.0% |
| 2019 FY | 1.37 Billion INR | -16.13% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 1.37 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 1.37 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 1.63 Billion INR | 85.23% |
| 2018 Q4 | 1.63 Billion INR | 0.0% |
| 2017 FY | 882.46 Million INR | -5.52% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q4 | 882.46 Million INR | 0.0% |
| 2017 Q2 | 985.03 Million INR | 0.0% |
| 2016 Q4 | 934 Million INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2016 FY | 934 Million INR | -9.51% |
| 2015 FY | 1.03 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.36 Billion INR | -44.141% |
| Biocon Limited | 307.95 Billion INR | 99.361% |
| Blue Jet Healthcare Limited | 2.13 Billion INR | 7.836% |
| Concord Biotech Limited | 1.74 Billion INR | -13.11% |
| Dishman Carbogen Amcis Limited | 39.53 Billion INR | 95.02% |
| FERMENTA BIOTECH LIMITED | 2.62 Billion INR | 25.045% |
| GENOMIC VALLEY BIOTECH LIMITED | 7.91 Million INR | -24771.102% |
| Lyka Labs Limited | 884.58 Million INR | -122.57% |
| Panacea Biotec Limited | 4.02 Billion INR | 51.027% |
| SAMSRITA LABS LIMITED | 32.93 Million INR | -5877.917% |
| Servoteach Industries Limited | 5275.00 INR | -37323634.597% |
| Supriya Lifescience Limited | 1.05 Billion INR | -85.966% |
| Syngene International Limited | 18.93 Billion INR | 89.604% |
| TAKE Solutions Limited | 969.78 Million INR | -103.018% |
| Titan Biotech Limited | 231.28 Million INR | -751.248% |
| Transgene Biotek Limited | 393.11 Million INR | -400.832% |
| Vanta Bioscience Limited | 724.23 Million INR | -171.849% |